For the first time, a CRISPR drug treats a child’s unique mutation
Pioneering CRISPR Therapy Targets Rare Genetic Defect in Pediatric Patient
Researchers are optimistic that this breakthrough will pave the way for additional young patients to receive life-changing treatment.
Source: The Economist Generated at: 2025-05-15 17:00:00 UTC



